Navigation Links
Early-stage Commercialization Success: Pharma Companies Adjust Resources in Light of Industry Changes
Date:4/4/2008

CHAPEL HILL, N.C., April 4, 2008 /PRNewswire/ -- Companies align commercial and portfolio management employees by therapeutic area. For a company with an annual sales volume of $10 to 20 billion, on average nine marketing FTEs are assigned to the early-stage commercialization team along with approximately eight portfolio managers. At companies with smaller sales volumes, the ratio is approximately four to three, commercial to portfolio management staff, according to a study by pharmaceutical benchmarking firm Best Practices, LLC.

In light of a changing industry with heightened focus on research and development, pharmaceutical companies are now significantly increasing resources to support for early-stage commercialization.

The benchmarking report, "Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence," available with a complimentary study summary online at http://www3.best-in-class.com/rr924.htm, provides extensive insight into how pharmaceutical, biotech and medical device companies are preparing their newest employees for the competitive marketplace in which they are being asked to excel.

Best Practices, LLC gathered valuable best practices and operating tactics from leading pharmaceutical companies, including Amgen, Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Procter & Gamble, Roche, Sanofi-Aventis and Wyeth. They will help executives build and manage strong teams that can excel across functions, units and regions.

Cross-function collaboration is greatly improved through many methods, including structuring jobs with overlapping responsibilities, basing rewards on group performance, designing procedures so that employees with different jobs are better able to collaborate, and laying out work areas so that people can see one another's work and share lessons learned.

This benchmarking report highlights the following areas of cross- functional team management:

-- Cross-Functional Team Structures

-- Collaboration and Productivity Processes

-- People Management

-- Resource Allocation

-- Decision-Making Processes

-- Communication and Collaboration

For additional sample practices and metrics, download the free study summary at http://www3.best-in-class.com/rr924.htm, or contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com for more information.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Exercise and yoga improves quality of life in women with early-stage breast cancer
2. Research highlights important indicators of early-stage ovarian cancer
3. Protein Linked With Poor Prognosis in Early-Stage Breast Cancer
4. OmniGuide Begins European Commercialization
5. Creating Effective Cross-Functional Teams for Pharmaceutical Commercialization Success
6. Anesiva to Unveil Zingo(TM) Commercialization Plans
7. China Medicines ADTZ Project Has Been Selected as One of Six Patent Commercialization Projects in Guangdong Province
8. IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities
9. Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
10. Pharmaceutical Product Commercialization: Enabling Teams to Excel
11. Building Better Launch Teams for Pharmaceutical Commercialization Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Chicago, Illinois (PRWEB) , ... March 29, 2017 ... ... Visio Stencils Device Library for documenting and diagramming network and data center assets ... , NetZoom subscribers can request new equipment shapes for free and download ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the ... the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony ... Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies ... directly address the resolution to globally reduce the harmful use of alcohol set ... FDA and TTB approved ingredients that when infused into alcohol, renders the alcohol ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 On March 28, the ... treat adult patients with relapsing forms of multiple sclerosis ... the first drug approved by the FDA for PPMS. ... care professional.  "Multiple sclerosis can have ... Billy Dunn , M.D., director of the Division of ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, ... of USD 55.8 billion by 2025. The projection takes into consideration the ... and a more open approach towards cannabis products around the world. In ... , North Dakota , Ohio , ...
(Date:3/29/2017)... , March 29, 2017 FinancialBuzz.com News ... The U.S. ... According to a new report published by New Frontier Data, the ... The accelerating pace of cannabis legalization in the United ... cannabis, are considered to be a major factor that drives growth ...
Breaking Medicine Technology: